RESEARCH ARTICLE


Azithromycin and Reported Increased Risk of Cardiovascular Death



Kelly N. Koenig*, Craig G. Burkhart
Azithromycin and Reported Increased Risk of Cardiovascular Death


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 477
Abstract HTML Views: 1388
PDF Downloads: 643
Total Views/Downloads: 2508
Unique Statistics:

Full-Text HTML Views: 334
Abstract HTML Views: 845
PDF Downloads: 437
Total Views/Downloads: 1616



Creative Commons License
© 2012 Koenig and Burkhart

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the College of Medicine, University of Toledo, 3000 Arlington Avenue, Toledo, OH 43614, USA; Tel: 1-419- 890-7798; E-mail: kelly.koenig@rockets.utoledo.edu


Abstract

Contrary to previous reports, azithromycin has now been associated with arrythmias and sudden cardiac deaths. There is a need for careful consideration of these risk factors with this drug especially when prescribing for the elderly. A more thorough screening of cardiovascular risk prior to starting azithromycin may also be warranted.

Keywords: Azithromycin, cardiac death, arrythmias.